Tuberculosis

Lights and shadows in the current diagnostic landscape

Luca Norbis, Paolo Miotto, Riccardo Alagna, Daniela M. Cirillo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Despite the improvements in the global fight against tuberculosis (TB), critical points still remain and fuel the epidemic. Even today, only 30% of the estimate number of people suffering from TB worldwide are correctly diagnosed, and lower proportions of cases are diagnosed in high-TB-burden, low-resource settings. Current TB diagnostics are still suboptimal in their performance for childhood TB, smear-negative TB, extrapul-monary TB, HIV-TB and drug-resistant TB. Furthermore, there is no gold standard test for the identification of latent TB infection status. Improving diagnosis is therefore a strategic goal in TB research, and the pipeline of diagnostic tools is rapidly growing: new ways of performing "old" tests (e.g. sputum smear microscopy) and completely innovative tools (e.g. new technologies for molecular diagnosis) are under investigation or have already been endorsed by WHO. Some of the structural limits of current TB diagnostics are likely to be overcome by such new tools, but research is still needed. Finally, the roll-out of new technologies and the development of newer ones will necessarily have to take into account the diagnostic needs of each context they are directed to (point-of-need testing approach), together with the logistic, economic and technical constraints present in the majority of high-TB-burden settings.

Original languageEnglish
Pages (from-to)111-120
Number of pages10
JournalNew Microbiologica
Volume36
Issue number2
Publication statusPublished - Apr 2013

Fingerprint

Tuberculosis
Light
Technology
Latent Tuberculosis
Multidrug-Resistant Tuberculosis
Sputum
Research
Microscopy
Economics
HIV

Keywords

  • Diagnosis
  • Diagnostic algorithms
  • Point-of-need testing
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Tuberculosis : Lights and shadows in the current diagnostic landscape. / Norbis, Luca; Miotto, Paolo; Alagna, Riccardo; Cirillo, Daniela M.

In: New Microbiologica, Vol. 36, No. 2, 04.2013, p. 111-120.

Research output: Contribution to journalArticle

@article{7f16392ecf5c477c9716cab5523bfaad,
title = "Tuberculosis: Lights and shadows in the current diagnostic landscape",
abstract = "Despite the improvements in the global fight against tuberculosis (TB), critical points still remain and fuel the epidemic. Even today, only 30{\%} of the estimate number of people suffering from TB worldwide are correctly diagnosed, and lower proportions of cases are diagnosed in high-TB-burden, low-resource settings. Current TB diagnostics are still suboptimal in their performance for childhood TB, smear-negative TB, extrapul-monary TB, HIV-TB and drug-resistant TB. Furthermore, there is no gold standard test for the identification of latent TB infection status. Improving diagnosis is therefore a strategic goal in TB research, and the pipeline of diagnostic tools is rapidly growing: new ways of performing {"}old{"} tests (e.g. sputum smear microscopy) and completely innovative tools (e.g. new technologies for molecular diagnosis) are under investigation or have already been endorsed by WHO. Some of the structural limits of current TB diagnostics are likely to be overcome by such new tools, but research is still needed. Finally, the roll-out of new technologies and the development of newer ones will necessarily have to take into account the diagnostic needs of each context they are directed to (point-of-need testing approach), together with the logistic, economic and technical constraints present in the majority of high-TB-burden settings.",
keywords = "Diagnosis, Diagnostic algorithms, Point-of-need testing, Tuberculosis",
author = "Luca Norbis and Paolo Miotto and Riccardo Alagna and Cirillo, {Daniela M.}",
year = "2013",
month = "4",
language = "English",
volume = "36",
pages = "111--120",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "2",

}

TY - JOUR

T1 - Tuberculosis

T2 - Lights and shadows in the current diagnostic landscape

AU - Norbis, Luca

AU - Miotto, Paolo

AU - Alagna, Riccardo

AU - Cirillo, Daniela M.

PY - 2013/4

Y1 - 2013/4

N2 - Despite the improvements in the global fight against tuberculosis (TB), critical points still remain and fuel the epidemic. Even today, only 30% of the estimate number of people suffering from TB worldwide are correctly diagnosed, and lower proportions of cases are diagnosed in high-TB-burden, low-resource settings. Current TB diagnostics are still suboptimal in their performance for childhood TB, smear-negative TB, extrapul-monary TB, HIV-TB and drug-resistant TB. Furthermore, there is no gold standard test for the identification of latent TB infection status. Improving diagnosis is therefore a strategic goal in TB research, and the pipeline of diagnostic tools is rapidly growing: new ways of performing "old" tests (e.g. sputum smear microscopy) and completely innovative tools (e.g. new technologies for molecular diagnosis) are under investigation or have already been endorsed by WHO. Some of the structural limits of current TB diagnostics are likely to be overcome by such new tools, but research is still needed. Finally, the roll-out of new technologies and the development of newer ones will necessarily have to take into account the diagnostic needs of each context they are directed to (point-of-need testing approach), together with the logistic, economic and technical constraints present in the majority of high-TB-burden settings.

AB - Despite the improvements in the global fight against tuberculosis (TB), critical points still remain and fuel the epidemic. Even today, only 30% of the estimate number of people suffering from TB worldwide are correctly diagnosed, and lower proportions of cases are diagnosed in high-TB-burden, low-resource settings. Current TB diagnostics are still suboptimal in their performance for childhood TB, smear-negative TB, extrapul-monary TB, HIV-TB and drug-resistant TB. Furthermore, there is no gold standard test for the identification of latent TB infection status. Improving diagnosis is therefore a strategic goal in TB research, and the pipeline of diagnostic tools is rapidly growing: new ways of performing "old" tests (e.g. sputum smear microscopy) and completely innovative tools (e.g. new technologies for molecular diagnosis) are under investigation or have already been endorsed by WHO. Some of the structural limits of current TB diagnostics are likely to be overcome by such new tools, but research is still needed. Finally, the roll-out of new technologies and the development of newer ones will necessarily have to take into account the diagnostic needs of each context they are directed to (point-of-need testing approach), together with the logistic, economic and technical constraints present in the majority of high-TB-burden settings.

KW - Diagnosis

KW - Diagnostic algorithms

KW - Point-of-need testing

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84878878812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878878812&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 111

EP - 120

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 2

ER -